Inhibitors of human immunodeficiency virus replication
The disclosure generally relates to compounds of formula I, including compositions and methods for treating human immunodeficiency virus (HIV) infection. The disclosure provides novel inhibitors of HIV, pharmaceutical compositions containing such compounds, and methods for using these compounds in the treatment of HIV infection.
Bristol-Myers Squibb Company
A C C C
A61P C07D C07D C07D
inventional inventional inventional inventional
Weixu Kevin Annapurna B. Narasimhulu Stanley Samuel Guo Manoj Zhongyu David R.
Zhai Peese Pendri Naidu D'Andrea Gerritz Li Patel Wang Langley